KNSA
Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A

2,477
Mkt Cap
$2.87B
Volume
402,062.00
52W High
$39.79
52W Low
$17.82
PE Ratio
943.31
KNSA Fundamentals
Price
$38.77
Prev Close
$38.90
Open
$38.87
50D MA
$36.31
Beta
0.72
Avg. Volume
440,054.38
EPS (Annual)
-$0.6047
P/B
5.80
Rev/Employee
$1.34M
Loading...
Loading...
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
315

Frequently Asked Questions

What is Market Cap of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
What is the 52-week high for Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
What is the 52-week low for Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
What is Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price today?
What was Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
What is the 50-day moving average of Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A?
How many employess does Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A has?

Latest KNSA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.